• About Us
    • Contact Us
    • Login
    • ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • #GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
About Us Contact Us Login ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • 0 CME Hours
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • #GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
#Grand Rounds

Large for Gestational Age Infants: How Does First Stage of Labor Differ?

image_pdfFavoriteLoadingFavorite

BACKGROUND AND PURPOSE:

  • Blankenship et al. (AJOG, 2019) evaluated first stage labor progress for large for gestational age (LGA) infants

METHODS:

  • Retrospective cohort study (2004 to 2014)
  • Participants
    • Term | Vertex | Singleton
    • Reached 10-cm cervical dilation
  • Definitions
    • LGA: Birthweight >90th percentile for gestational age
    • AGA: Birthweight 10th to 90th percentile for gestational age
    • First stage of labor: >3 cm cervical dilation
  • Study design and data analysis
    • Labor curves were constructed: Compared between LGA and AGA
    • Median duration of labor after 3-cm cervical dilation stratified by
      • Actual infant birthweight | Parity | Labor onset (e.g., spontaneous, augmentation, induction) | Pregestational DM or GDM | BMI
    • Data on pelvic shape, fetal position, and uterine infection not available
    • Multivariate analysis adjusted for confounding factors

RESULTS:

  • 17,097 women included
    • AGA: 92.7%
    • LGA: 7.3%
      • Nulliparous: 30.9%
      • Induction: 37.0%
      • Obese: 68.8%
      • Pregestational DM or  GDM: 12.6%
  • LGA: Slower progression from 3- to 10-cm cervical dilation  (P<0.01)
    • LGA: Median, 8.57 hours (5th, 95th percentile, 2.95, 24.86)
    • AGA: 6.46 hours (5th, 95th percentile, 2.23, 18.74)
  • LGA: Dilation from 6–10 cm progressed slower in
    • Nulliparous compared with multiparous women (P<0.01)
      • Nulliparous: 3.28 hours (5th, 95th percentile, 0.71, 15.16)
      • Multiparous: 2.03 hours (5th, 95th percentile, 0.44, 9.39)
    • Obese compared with not obese women (P<0.01)
      • Obese: 2.36 hours (5th, 95th percentile, 0.51, 10.91)
      • Not obese: 1.79 hours (5th, 95th percentile, 0.39, 8.31)
  • Labor curves did not differ between LGA and AGA for the following
    • Labor onset (nonaugmented spontaneous labor vs induced labor)
    • Pregestational DM or gestational diabetes mellitus

CONCLUSION:

  • Authors acknowledge study limitations including that study can address associations and not causality
  • Women with LGA infants take longer to reach the second stage of labor vs AGA
    • The difference greatest in nulliparous and obese women once in the active phase of labor (6-10 cm)
  • Labor onset and the presence of diabetes or gestational diabetes do not seem to affect the duration of the first stage of labor after 3-cm cervical dilation
  • Authors suggest based on data in this study
    • Obesity results in delay through stage 1 because greater adipose tissue deposits in the pelvis and weaker contractions
    • Metabolic DM effects seem less likely to alter labor curve patterns
  • Authors recommend further studies that will incorporate the following
    • Use EFW to identify macrosomia “…because this would provide greater clinical insight into anticipated labor progression, influence prospective labor management in cases of suspected fetal macrosomia, and enable comparison with our labor curves that were constructed from postnatal infant birthweight”

Learn More – Primary Sources:

First stage of labor progression in women with large-for-gestational age infants

Now You Can Get ObG Clinical Research Summaries Direct to Your Phone, with ObGFirst

Try it Free  »

image_pdfFavoriteLoadingFavorite
< Previous
All #Grand Rounds Posts
Next >

Related ObG Topics:

Macrosomia: Determination of EFW and Recommendations for Delivery
Are Large-for-Gestational Age Pregnancies at an Increased Risk of Stillbirth?
Does Early Accelerated Fetal Growth Increase the Risk for LGA and Macrosomia?
Universal Ultrasound Screening for Fetal Macrosomia: Is It Cost-Effective?

Sections

  • COVID-19
  • Alerts
  • OB
  • GYN
    • GYN
    • Sexual Health
  • 2T US Atlas
  • The Genome
  • Primary Care
  • Your Practice
  • #Grand Rounds
  • My Bookshelf
  • Now@ObG
  • Media

ObG Library

  • Hysteroscopy
  • Fertility
  • Site Map/
  • © ObG Project/
  • Terms and Conditions/
  • Privacy/
  • Contact Us/
© ObG Project
SSL Certificate


  • Already an ObGFirst Member?
    Welcome back

    Log In

    Want to sign up?
    Get guideline notifications
    CME Included

    Sign Up

Get Guideline Alerts Direct to Your Phone
Try ObGFirst Free!

Sign In

Lost your password?

Sign Up for ObGFirst and Stay Ahead

  • - Professional guideline notifications
  • - Daily summary of a clinically relevant
    research paper
  • - Includes 1 hour of CME every month

ObGFirst Free Trial

Log In to ObG First

Please log in to access OBGFirst and the 2T Ultrasound Atlas

Password Trouble?

Sign Up for ObGFirst

  • - Access 2T US Atlas
  • - Guideline notifications
  • - Daily research paper summaries
  • - And lots more!

ObG First Free Trial

Media - Internet

Computer System Requirements

OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Jointly provided by

NOT ENOUGH CME HOURS

It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan

Subscribe

JOIN OBGFIRST AND GET CME/CE CREDITS

One of the benefits of an ObGFirst subscription is the ability to earn CME/CE credits from the ObG entries you read. Tap the button to learn more about ObGFirst

Learn More
Leaving ObG Website

You are now leaving the ObG website and on your way to PRIORITY at UCSF, an independent website. Therefore, we are not responsible for the content or availability of this site